Conference Chair

Christopher M. Mikson

Partner
Mayer Brown LLP

Speakers

Ginny Beakes-Read

Executive Director/Special Counsel, Regulatory Strategy and Law
Eisai Inc.

Ryan P. Blaney

Member
Cozen O’Connor

Drugs and Biologics: Labeling

September 14, 2017 1:45 pm

Naomi J.L. Halpern

Counsel
Arent Fox LLP

Robert E. Johnston

Partner
Hollingsworth LLP

Amy Judge-Prein

Partner
Faegre Baker Daniels LLP

Kurt R. Karst

Director
Hyman, Phelps & McNamara, P.C.

PART 2: Hatch-Waxman and BPCIA Overview

September 14, 2017 3:30 pm

Scott Lassman

Partner
Goodwin Procter LLP

Andrea Masciale

Vice President, Regulatory Policy & Global Analytics
Johnson & Johnson Worldwide Government Affairs & Policy

Gary C. Messplay

Partner
King & Spalding

Donna M. Meuth

Associate General Counsel, Intellectual Property
Eisai Inc.

Joseph G. Poluka

Partner
Blank & Rome LLP

Deborah M. Shelton

Partner, Leader of the Food & Drug Law Practice
McCarter & English, LLP

Brian Walsh

Assistant General Counsel – Intellectual Property
Bristol-Myers Squibb

Drugs and Biologics: Labeling

September 14, 2017 1:45 pm

Michael A. Walsh

Partner
Strasburger & Price, L.L.P.

Donald R. Ware

Partner and Chair of Intellectual Property Department
Foley Hoag LLP

PART 2: Hatch-Waxman and BPCIA Overview

September 14, 2017 3:30 pm